2 year fixed-term contract, full time, start date: immediate
Deregulated signaling of receptor tyrosine kinases (RTK) are a hallmark of glioblastomas (GBM) and many therapeutic attempts are undertaken to interfere with hyperactive intracellular signaling. Attempts to map the exact phosphorylation status of the RTK substrates is hampered by complicated phosphorylation pattern. By combining the extensive expertise in both Mass Spectrometry and GBM Biology at the Luxembourg Institute of Health, this project aims to characterize and quantify phospho-sites involved in GBM cell signaling with superior level of accuracy.
The proteomics laboratory is equipped with the latest instrumentation in high-resolution mass spectrometry. Close collaborations with the other groups of the LIH offer a wide spectrum of modern techniques. Especially the close collaborations of the proteomics laboratory with the bioinformatics group allows the rapid development of specialized techniques and tools to address specific scientific challenges.
More information regarding the unit can be found here : www.lih.lu/dittmar
Researchers are supported by easy access to scientific expertise, well-equipped facilities, an active seminar program as well as the possibility for close collaborations with the university and other research institutes.
Located in Luxembourg, LIH offers the opportunity to work in a dynamic, international and multilingual environment that values personal respect and professional achievement based on the highest intellectual and ethical standards. The remuneration for this position shall be based on qualification and experience.
Applications including a cover letter and a full curriculum vitae should be sent until 31st August 2017 through our website www.lih.lu/jobs. Ref.: VD/PDR0717/GD/GENPRO